Billiontoone, Inc. (NASDAQ:BLLN) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Billiontoone, Inc. (NASDAQ:BLLN) have earned an average rating of “Hold” from the eleven analysts that are covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating on the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $126.25.

A number of brokerages recently weighed in on BLLN. Zacks Research cut shares of Billiontoone from a “hold” rating to a “strong sell” rating in a report on Monday, August 31st. Wall Street Zen lowered Billiontoone from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. BTIG Research lowered their target price on Billiontoone from $142.00 to $130.00 and set a “buy” rating for the company in a research note on Thursday, August 6th. Canaccord Genuity Group started coverage on Billiontoone in a research report on Wednesday, September 2nd. They issued a “buy” rating and a $120.00 price target on the stock. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Billiontoone in a research note on Friday, September 18th.

Insider Buying and Selling

In other Billiontoone news, CTO David Tsao sold 20,000 shares of Billiontoone stock in a transaction dated Wednesday, September 9th. The stock was sold at an average price of $98.77, for a total transaction of $1,975,400.00. Following the completion of the sale, the chief technology officer directly owned 1,000 shares of the company’s stock, valued at $98,770. The trade was a 95.24% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Thomas P. Lynch sold 35,112 shares of the company’s stock in a transaction dated Thursday, September 17th. The stock was sold at an average price of $110.33, for a total value of $3,873,906.96. Following the transaction, the insider directly owned 700 shares of the company’s stock, valued at approximately $77,231. This represents a 98.05% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 255,107 shares of company stock worth $29,318,494 over the last 90 days. 50.22% of the stock is owned by insiders.

Institutional Investors Weigh In On Billiontoone

Several institutional investors have recently added to or reduced their stakes in the business. Adams Street Partners LLC acquired a new stake in shares of Billiontoone in the 4th quarter valued at about $140,063,000. Wasatch Advisors LP grew its position in shares of Billiontoone by 40.2% during the second quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock worth $62,160,000 after acquiring an additional 148,446 shares during the last quarter. Emerald Advisers LLC increased its holdings in shares of Billiontoone by 26.8% in the 1st quarter. Emerald Advisers LLC now owns 239,562 shares of the company’s stock valued at $18,911,000 after acquiring an additional 50,613 shares during the period. Capital International Investors purchased a new stake in Billiontoone in the 4th quarter valued at $14,568,000. Finally, Emerald Mutual Fund Advisers Trust boosted its stake in Billiontoone by 11.9% during the 1st quarter. Emerald Mutual Fund Advisers Trust now owns 132,206 shares of the company’s stock worth $10,436,000 after purchasing an additional 14,072 shares during the period.

Billiontoone Trading Up 0.1%

NASDAQ BLLN opened at $105.90 on Friday. The firm’s 50-day moving average is $107.05 and its two-hundred day moving average is $99.83. The stock has a market capitalization of $5.00 billion and a P/E ratio of 151.29. Billiontoone has a 12 month low of $61.96 and a 12 month high of $150.44. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31.

Billiontoone (NASDAQ:BLLN) last posted its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, meeting the consensus estimate of $0.15. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. The firm had revenue of $109.45 million during the quarter. On average, sell-side analysts anticipate that Billiontoone will post 0.83 earnings per share for the current year.

About Billiontoone

BillionToOne, Inc (NASDAQ:BLLN) is a molecular diagnostics company that develops blood-based genetic tests designed to provide more information from small amounts of cell-free DNA. The company’s platform uses proprietary molecular counting technology to improve the sensitivity and accuracy of diagnostic testing.

BillionToOne’s primary business is reproductive health testing. Its UNITY portfolio is designed to support prenatal screening, including testing for chromosomal conditions and single-gene disorders, and is intended to provide physicians and expectant parents with information from a maternal blood sample.